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Physicians are increasingly being asked to
evaluate persons who report symptoms
thought to be associated with indoor (nonin-
dustrial) environments where various types of
environmental problems have been identi-
fied. Although occupants of moisture-dam-
aged buildings may experience increased
respiratory symptoms (1), the clinical impor-
tance of moisture damage remains unclear in
situations where occupants report nonspeciﬁc
building-related illnesses (2). There has been
particular concern over potential health
effects from exposure to fungi that produce
mycotoxins (3). This concern has received
much public attention (4) and has led to rec-
ommendations for the remediation of build-
ings based in part on the reported association
of various health effects with exposure to
mycotoxins (5). 
In October 1998, the National Institute
for Occupational Safety and Health (NIOSH)
received a request from a local health depart-
ment to assist in the evaluation of potential
occupational exposure to fungi among work-
ers at a hotel. A preliminary visual inspection
of the hotel revealed that many areas of the
building had widespread fungal growth,
which appeared to be the result of frequent
and severe water damage. Our subsequent
activities included an environmental survey
to assess potential fungal exposure and a
pilot serologic survey to assess exposure of
workers to mycotoxins. During the same
period, clinical evaluation of a worker who
developed chronic restrictive lung disease
related to work duties in the hotel was per-
formed by physicians not directly related to
the NIOSH evaluation.
Case Presentation
Clinical evaluation. A 48-year-old white
male, without a prior history of pulmonary
disease or tobacco use, presented to his pri-
mary care physician in July 1998 with a 2-
month history of dry cough and a 1-week
history of fever and dyspnea. A chest exam
revealed scattered rhonchi and crackles on
the right side; an initial chest X ray was unre-
markable. Over a period of several months,
the patient was treated with several courses of
azithromycin for a pneumonitis of uncertain
etiology. Pulmonary function testing (Table
1) revealed a reduced forced vital capacity,
(FVC), forced expiratory volume in the ﬁrst
second of exhalation (FEV1), and total lung
capacity (TLC). The diffusing capacity cor-
rected for alveolar volume (DLCO/VA) was
normal.
Occupational history revealed that the
patient had been a hotel manager at one hotel
for the previous 14 years. Two months before
initial presentation, he and a co-worker began
assessing the extent of water damage and fun-
gal growth in hotel rooms after hotel guests
complained of water leakage and odors
(Figure 1). These assessments included strip-
ping wallpaper and making holes in walls; no
respiratory protection was worn. Shortly
thereafter, the patient reported the onset of a
nonproductive cough. The patient performed
these types of duties until the hotel was closed
in October 1998, 5 months after the initial
assessment for water damage. However, as the
primary supervisor for remediation of the
damaged areas, the patient continued to enter
all parts of the hotel. The patient had no prior
history of exposure to farms or other environ-
ments where he would have been exposed to
excessive amounts of fungi.
Seven months after his initial presenta-
tion, the patient was referred for further eval-
uation. Dyspnea and cough were noted to be
temporally related to his presence in the
hotel. His white blood cell count and ery-
throcyte sedimentation rate were normal. His
total IgE level was 346 IU/mL (normal range
0–99 IU/mL). Precipitating antibodies were
positive only to Thermoactinomyces vulgaris.
Speciﬁc IgG and IgE antibody responses to
Stachybotrys sp. were not elevated. A repeat
chest X ray was unremarkable, as was high-
resolution computed tomography (HRCT)
of the chest. A methacholine challenge test
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lative dose of methacholine (in milligrams)
that causes a 20% fall in FEV1 = 25 mg/mL
methacholine]. A repeat HRCT of the chest
performed several weeks later with inspiratory
and expiratory views was suggestive of an
interstitial mosaic pattern consistent with
bronchiolitis. Spirometry remained notable
for a moderate restrictive defect (Table 1).
Based on the patient’s history and laboratory
ﬁndings, he was advised to completely avoid
all exposure to his workplace (11 months after
the initial investigations for water damage).
The patient was subsequently referred
for bronchoscopy. Transbronchial biopsy
was unremarkable. Bronchoalveolar lavage
(BAL) initially was not performed. The
patient was given a provisional diagnosis of
restrictive lung disease consistent with a
chronic form of hypersensitivity pneumoni-
tis, and treatment was begun with high-dose
prednisone (120 mg/day). Repeat bron-
choscopy (4.5 months after the initial bron-
choscopy) revealed 12% lymphocytes in the
BAL ﬂuid (normal < 20%) and a CD4/CD8
ratio of 0.8 (laboratory reference > 1). On
the basis of continuing symptoms, evidence
of advancing restrictive lung disease (despite
removal from the workplace), and concern
over the side effects of prednisone, treatment
with methotrexate was initiated at 10
mg/week and was subsequently increased to
7.5 mg twice weekly as the prednisone was
gradually decreased. A repeat HRCT of the
chest was normal. The patient’s symptoms
gradually improved, while his lung function
remained stable (Table 1).
Environmental evaluation. Beginning in
November 1998, we conducted environmen-
tal surveys (including bulk and air sampling)
in a total of 19 rooms of the 10-story hotel.
Rooms that had experienced water damage
but that had not yet been remediated were
chosen for sampling; the objective was to
sample from a representative group of
affected rooms. We collected 14 bulk sam-
ples of materials that appeared to be contami-
nated with fungi for analysis with culture
techniques (all fungal samples were analyzed
by P & K Microbiology Services, Inc.,
Cherry Hill, NJ) (6). Using previously
described methods (6,7), we collected 18
samples to be analyzed for mycotoxins
(speciﬁcally trichothecenes, atranones, griseo-
fulvins, and phenylspirodrimanes), which can
be produced by Stachybotrys chartarum (syn-
onyms atra or alternans) and other fungi.
We collected air samples over a 2-day
period using culturable and nonculturable
methods. Concentrations of culturable air-
borne fungi were determined for 14 interior
building locations and 1 outdoor location
using the Andersen single-stage viable cas-
cade impactor (Andersen Instruments,
Smyrna, GA) at a calibrated flow rate of
28.3 L/min. We used the Air–O–Cell
(Zefon Analytical Accessories, St. Petersburg,
FL) at a calibrated ﬂow rate of 15 L/min (6)
to determine airborne concentrations of total
spores (nonculturable method) at 13 loca-
tions throughout the building at the same
locations as the culturable samples and at an
outdoor location. 
Fungal concentrations from the bulk
material samples ranged from 8.8 × 104 to 5.2
× 107 colony forming units (CFU) per gram
of material. The predominant fungi identi-
ﬁed included Acremonium sp., Alternaria sp.,
Aspergillus niger, Aspergillus sydowii, Mucor
sp., Penicillium sp., Phoma sp., Stachybotrys
chartarum, Ulocladium chartarum, and yeasts.
Among the identified fungi, Aspergillus sp.,
Penicillium sp., and Stachybotrys chartarum
are known to be capable of producing
mycotoxins. Mycotoxins produced by
Stachybotrys chartarum (or Memnoniella echi-
nata) were identiﬁed in 8 of 18 samples. The
complex trichothecenes, satratoxin and ror-
idin, produced by Stachybotrys chartarum,
were found in minute quantities. Atranones,
spirocyclic compounds (phenylspirodri-
manes) produced by Stachybotrys chartarum
and M. echinata, and epidechlorogriseoful-
vin, produced by M. echinata, were also
identiﬁed.
Results of the culturable air samples are
presented in Table 2. Two of the samples
were overloaded with fungal growth so
colonies could not be counted; results in
Table 2 reﬂect the 12 samples that could be
counted. In water-damaged areas, Penicillium
sp. and Aspergillus sp. were the predominant
genera detected. Stachybotrys was identified
from 5 of 12 sampling locations. Results of
the nonculturable techniques were consistent
with those obtained by culturable sampling,
with Stachybotrys identified from 13 of 14
sample locations.
Laboratory evaluation. Because there are
currently no useful biological monitoring
techniques to assess exposure to mycotoxins,
we conducted a pilot serologic evaluation
using a test under development to identify
speciﬁc IgG and IgM antibodies to roridin (a
tricothecene mycotoxin known to be pro-
duced by several different fungi including
Stachybotrys species). Tricothecene mycotox-
ins are potent irritants and may act as hap-
tens, which bind constitutive proteins
exerting an immune response similar to what
has been described for other xenobiotics. De
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Table 1. Pulmonary function testing of case patient(height 74 in; weight 226 lb).
Date Dec 1998 Feb 1999 Aug 1999 Dec 1999 Feb 2000
FVC (L) 3.60 (66%) 3.48 (64) 3.31 (59) 3.19 (57) 3.17 (57)
FEV1 (L) 2.91 (66%) 2.86 (65) 2.76 (63) 2.55 (58) 2.59 (59)
FEV1/FVC 0.81 (100%) 0.81 (99) 0.83 (106) 0.80 (102) 0.82 (104)
DLCO/VA (L/min/mmHg) 5.98 (139) 5.66 (131) ND ND ND
TLC (L) 5.0 (66) 4.8 (63) ND ND ND
ND, not done. Values in parentheses are observed values expressed as a percentage of predicted values.
Table 2. Results of air sampling for culturable fungi (n = 12).
Median indoor  Outdoor  Predominantc  Predominantc
Agar mediaa concentration (CFU/m3)b concentration (CFU/m3) genera/species indoors genera outdoors
Cornmeal agar  1,200 (294–2,690) 380 Penicillium sp. (100)d Cladosporium sp.
Aspergillus sp. (83)
Cladosporium sp. (100)
Stachybotrys chartarum (42)
Dichloran glycerol  1,350 (319–2,745) 419 Penicillium sp. (100) Cladosporium sp.
Aspergillus sp. (100)
Cladosporium sp. (100)
aCornmeal agar is a selective nutrient medium to promote the growth of Stachybotrys species; dichloran glycerol is a selective nutrient medium to promote the growth of low–moisture
tolerating fungi (i.e., xerophiles). bValues in parentheses indicate range. cGenera most frequently found across all samples. dValues in parentheses indicate the percentage of samples in
which each fungus was found.
Figure 1. Water damage and fungal growth in a
room with wallpaper stripped from walls.novo biosynthesis of antibodies from myco-
toxin exposure has been shown for related
mycotoxins such as aﬂatoxins found in food
(8). In addition, cows exposed to mycotoxins
in their feed have been shown to produce
anti-mycotoxin antibodies (9). Roridin-A IgG
antibodies, generated in animals, have been
shown to be specific for macrocyclic tri-
cothecenes (roridin is a type of macrocyclic
tricothecene) (10). 
In a study approved by the NIOSH
Human Subjects Review Board, personnel
lists of former hotel employees (total of 90
full- or part-time employees) were reviewed
with hotel management to determine
exposed (persons who had routinely worked
in the fungi-contaminated areas) and unex-
posed (persons who had worked in areas
found not to be grossly contaminated with
fungi) workers. Employee recruitment was
difﬁcult because the hotel was closed at the
time of our evaluation and employees were
no longer employed at the hotel. Eight
employees agreed to participate in the sur-
vey, including six exposed and two unex-
posed employees. The two hotel employees
who participated in the discovery and initial
mitigation of the water problem (including
the hotel manager), and who were the per-
sons most highly exposed to the fungal cont-
amination, were included among the six
exposed employees. After informed consent
was obtained, a serum sample was collected
from each participant. A brief questionnaire
to assess job duties, medical history, and cur-
rent symptoms was also administered to par-
ticipants. We did not perform clinical
examinations of study participants.
We performed enzyme-linked immuno-
sorbent assays (ELISA) for roridin-hemisuc-
cinate–human serum albumin (RH-HSA)-
speciﬁc IgG antibodies on each serum sam-
ple. Fifty microliters of a 50 µg/mL solution
of RH-HSA was placed in each well and
incubated overnight at 4°C. Each well was
then washed three times with phosphate-
buffered saline (0.02 M phosphate buffer,
pH 7.4) containing 0.91 M sodium chloride
and Tween; a similar wash was repeated
between all subsequent steps. Aliquots (200
µL) of each diluted serum sample (1:10 in
5% bovine serum albumin–deionized water)
were added to the wells and allowed to incu-
bate at room temperature for 2 hr. After
washing, 100 µL of goat anti-human IgG or
IgM (whole molecule) alkaline phosphatase
conjugate (Sigma Chemical Co., St. Louis,
MO) was added to each well and incubated
for 2 hr at room temperature. The plates
were again washed and 100 µL of 0.6 mM
disodium p-nitrophenyl phosphate (Sigma
Chemical Co.) substrate solution, diluted in
alkaline glycine buffer (0.05 M glycine and
0.5 mM magnesium chloride, pH 10.4), was
added. After 10–15 min, the reactions were
read on an automated ELISA plate reader.
Each serum was tested in triplicate. We used
seven stored sera obtained from unrelated
NIOSH studies (from persons living in the
same geographic area as the hotel but with
no known contact to this hotel or excessively
moldy environments) as assay controls. A
response was deﬁned as positive if a subject’s
serum optical density (OD) was greater than
the assay control sera’s mean OD + 3 SD.
The participants in the survey included
three males and five females. The median
length of employment at the hotel was 4
years (range: 1–14 years). Persons considered
exposed worked in housekeeping, mainte-
nance, or supervisory jobs, whereas the two
unexposed persons worked in the bar/restau-
rant area. Among the eight sera samples, two
had elevated IgG antibody titers to RH-
HSA. The two individuals with elevated lev-
els included one who was considered exposed
and one who was considered unexposed. The
hotel manager (case patient) did not have an
elevated antibody level. No exposed or unex-
posed individuals gave evidence of specific
IgM antibodies to RH-HSA.
Although exposed workers reported a
spectrum of symptoms, some of which were
reported to improve away from work, none
of the workers were identified during our
interview as having a clinical illness similar
to that of the case patient. We did not per-
form systematic clinical evaluations of survey
participants. 
Discussion
Fungi are ubiquitous in the environment,
and most individuals are exposed to them on
a daily basis. Many fungi are capable of pro-
ducing mycotoxins, which suggests that
most people have some level of regular expo-
sure to mycotoxins. An important aspect of
evaluating whether health effects may be
related to mycotoxin exposure is documenta-
tion of exposure (11). This is difficult
because there are currently no reliable expo-
sure indicators for mycotoxins. The standard
used to associate health effects to mycotoxin
exposure is the measurement of mycotoxins
in bulk samples obtained from materials
such as walls, ceiling tiles, and air ducts
(12,13). Although the identification and
quantification of several mycotoxins has
been recently accomplished using mono-
clonal antibodies and enzyme immunoas-
says, these methods have had limited use in
ﬁeld evaluations (10,14–16). The pilot sero-
logic survey of this investigation was not able
to distinguish between exposed and unex-
posed workers in a building heavily contami-
nated with mycotoxin-producing fungi.
Although this laboratory testing did yield
evidence that individuals may make speciﬁc
IgG antibodies to roridin, the source of the
exposure that led to this response cannot be
determined from our data. Further studies
are needed to determine the validity and
speciﬁcity of this antibody testing in humans.
This case report emphasizes the impor-
tance of a careful occupational and environ-
mental history because earlier recognition and
avoidance of exposure to the suspected causal
antigens may have reduced the degree of the
patient’s pulmonary disease. Furthermore,
this case illustrates the complexity of establish-
ing a deﬁnitive relationship between a speciﬁc
illness and exposure to bioaerosols in general,
or to any speciﬁc component of a bioaerosol
(such as a mycotoxin).
In this case, the worker who developed
chronic lung disease was likely exposed to an
unusually high concentration of airborne
fungi while investigating water incursion into
the building. Although a speciﬁc diagnosis or
cause of his pulmonary disease could not be
conﬁrmed, environmental sampling revealed
heavy growth and airborne dissemination of
many fungi, including several known to cause
hypersensitivity pneumonitis (HP) (17,18).
This worker fulﬁlled several of the major cri-
teria required for the diagnosis of HP (19),
including chronic respiratory symptoms com-
patible with HP, prolonged exposure to a
putative antigen, and recurrence of symptoms
upon reentry into the contaminated work-
place. Although there was no absolute lym-
phocytosis on BAL, the CD4/CD8 ratio was
decreased, which is consistent with HP.
The difficulty in making a definitive
diagnosis of HP is due in part to the incom-
plete understanding of the pathogenesis of
this disorder (20). A diagnosis of HP is fur-
ther complicated because HP can present in
acute, subacute, or chronic forms (21,22).
Prolonged, low-dose exposure to inciting
agents has been thought to predispose to a
more chronic presentation (21). The clinical
manifestations of the chronic form of HP,
which often include cough and dyspnea
without the systemic manifestations more
commonly seen in the acute form (20,21),
are compatible with the case patient’s
presentation.
Figure 2 provides an algorithmic approach
that can be helpful in the clinical evaluation
of a person who, based on a history and
physical examination, is suspected of having
an illness associated with bioaerosol expo-
sure. After infectious processes are appropri-
ately evaluated and found to be unlikely,
then further evaluation is warranted.
Hypersensitivity illnesses that must be con-
sidered in such an evaluation can be catego-
rized broadly as having asthmatic or
pneumonitis features, although there may be
considerable overlap between the two.
Although inhalation fevers (e.g., humidiﬁer
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tory illness, they should also be considered in
the differential diagnosis. Detailed reviews
related to the diagnosis of these illnesses are
available to supplement the broad algorithm
presented here (23).
In the last several years, reports have
implicated exposure to Stachybotrys chartarum
as being associated with acute pulmonary
hemorrhage/hemosiderosis among infants or
children (24). However, in a recent extensive
review, the Centers for Disease Control and
Prevention (13) concluded that evidence from
currently available studies is not sufﬁcient to
support an association between acute pul-
monary hemorrhage/hemosiderosis and expo-
sure to Stachybotrys chartarum, and that
further investigation of acute pulmonary
hemorrhage/hemosiderosis in infants is
needed. Our ﬁndings reinforce the difﬁculty
investigators have had in attempting to deter-
mine actual exposure to mycotoxins.
Conclusion
Building-related illnesses include a variety
of recognized disease entities that are
characterized by objective clinical findings
related to specific exposures in the indoor
environment (2). These illnesses are pre-
ventable if greater efforts at improving
building design, construction, indoor envi-
ronmental controls, and maintenance to
prevent or reduce exposure to potential etio-
logic agents are implemented. The clinical
and environmental evaluations we have pre-
sented emphasize the need for further
research involving biomarkers and health
effects related to bioaerosol exposure. Such
research should focus on identifying accept-
able levels of indoor airborne microorgan-
isms and mycotoxins and developing better
methods for assessing their effects on
human health. In the absence of tools spe-
cific for evaluation of possible mycotoxin-
related illness, the clinical evaluation of
suspected building-related respiratory illness
should follow standard guidelines.
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Figure 2. Approach to patients with suspected building-related illness from bioaerosol exposure: compo-
nents of clinical evaluation when history and physical examination is suggestive of respiratory illness.
Abbreviations: Ab, antibody; CBC, complete blood count; CXR, chest X ray; ESR, erythrocyte sedimentation
rate; PFT, pulmonary function test. 
aSerology for histoplasmosis and Lp1 antigen (urine) to evaluate for Legionella infection should also be considered.
bExtent of environmental assessment will depend on multiple factors. cHRCT should be performed even with normal CXR.
dPFT (with bronchodilator administration) with lung volumes and diffusing capacity corrected for alveolar volume.
eEvaluation for IgE-mediated immediate hypersensitivity. fEvaluation for precipitating antibodies to antigens present in
the environment. gShould also include CD4/CD8 ratio, fungal/bacterial cultures, and histology.
Environmental
assessmentb
Rule out infectious causes CXR, sputum cultures/smear, CBC with differentiala
HRCTc chest PFT with DLCOd
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If infectious process unlikely
Interstitial infiltrate
Supportive findings Supportive findings
Precipitating Ab
Elevated ESR
Specific hypersensitivity
Elevated total IgE
Restrictive pattern
Decreased DLCO
Obstructive pattern and/or
hyperreactive airways
Skin prick testinge
Precipitating Ab
Total IgE
ESR
Pneumonitis Asthmatic
Bronchoscopy with
bronchoalveolor lavage and biopsyg
Peak expiratory flow testing
at work and away from work